576 related articles for article (PubMed ID: 18242925)
21. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
Johnson M; Bakas T
J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
[TBL] [Abstract][Full Text] [Related]
22. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
[TBL] [Abstract][Full Text] [Related]
23. Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub.
Sairanen T; Soinila S; Nikkanen M; Rantanen K; Mustanoja S; Färkkilä M; Pieninkeroinen I; Numminen H; Baumann P; Valpas J; Kuha T; Kaste M; Tatlisumak T;
Neurology; 2011 Mar; 76(13):1145-52. PubMed ID: 21368283
[TBL] [Abstract][Full Text] [Related]
24. Improving Telestroke Treatment Times in an Expanding Network of Hospitals.
Sanders KA; Patel R; Kiely JM; Gwynn MW; Johnston LH
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):288-91. PubMed ID: 26654667
[TBL] [Abstract][Full Text] [Related]
25. Telestroke: rapid treatment of acute ischemic stroke patients using telemedicine in a Singapore emergency department.
Ang SH; Tan C; Singh R
Eur J Emerg Med; 2013 Oct; 20(5):322-6. PubMed ID: 22932067
[TBL] [Abstract][Full Text] [Related]
26. Why are eligible thrombolysis candidates left untreated?
Hills NK; Johnston SC
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
[TBL] [Abstract][Full Text] [Related]
27. The first 100 thrombolysis cases in a novel Scottish mesh telestroke system.
Hill E; Whitehead M; MacInnes B; Ellis G; Talbot A; Brodie F; Hughes N; Beggs S; Barber M
Scott Med J; 2013 Nov; 58(4):213-6. PubMed ID: 24215039
[TBL] [Abstract][Full Text] [Related]
28. Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
Hill MD; Barber PA; Demchuk AM; Sevick RJ; Newcommon NJ; Green T; Buchan AM
CMAJ; 2000 May; 162(11):1589-93. PubMed ID: 10862236
[TBL] [Abstract][Full Text] [Related]
29. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
[TBL] [Abstract][Full Text] [Related]
30. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
31. Targeting telestroke: benchmarking time performance in telestroke consultations.
Yang JP; Wu TC; Tegeler C; Xian Y; Olson DM; Kolls BJ
J Stroke Cerebrovasc Dis; 2013 May; 22(4):470-5. PubMed ID: 23642757
[TBL] [Abstract][Full Text] [Related]
32. Using routine data for quality assessment in NeuroNet telestroke care.
Theiss S; Günzel F; Storm A; Hausn P; Isenmann S; Klisch J; Ickenstein GW;
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):984-90. PubMed ID: 22365711
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
[TBL] [Abstract][Full Text] [Related]
34. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
[TBL] [Abstract][Full Text] [Related]
35. An analysis of business issues in a telestroke project.
Cho S; Khasanshina EV; Mathiassen L; Hess DC; Wang S; Stachura ME
J Telemed Telecare; 2007; 13(5):257-62. PubMed ID: 17697514
[TBL] [Abstract][Full Text] [Related]
36. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.
Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y
Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545
[TBL] [Abstract][Full Text] [Related]
37. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
[TBL] [Abstract][Full Text] [Related]
38. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
Hemmen TM; Meyer BC; McClean TL; Lyden PD
J Stroke Cerebrovasc Dis; 2008; 17(1):23-5. PubMed ID: 18190817
[TBL] [Abstract][Full Text] [Related]
39. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
;
Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
[TBL] [Abstract][Full Text] [Related]
40. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
